Chlorpyrifos exposure during neurulation: Cholinergic synaptic dysfunction and cellular alterations in brain regions at adolescence and adulthood

Developmental Brain Research

Volumn 148, Issue 1, 2004, Pages 43-52

  Qiao, Dan ^a   Seidler, Frederic J ^a   Abreu Villaça, Yael ^a   Tate, Charlotte A ^a   Cousins, Mandy M ^a   Slotkin, Theodore A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain development; Chlorpyrifos; Choline acetyltransferase; Cholinesterase; Development; DNA; Hemicholinium 3 binding; Muscarinic m2 acetylcholine receptor

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; CHLORPYRIFOS; CHOLINE ACETYLTRANSFERASE; HEMICHOLINIUM 3; MUSCARINIC M2 RECEPTOR;

ADOLESCENCE; ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN SYNAPTOSOME; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE; CHOLINERGIC SYNAPSE; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL EXPOSURE; FEMALE; GESTATIONAL AGE; HIPPOCAMPUS; MALE; NERVE CELL DIFFERENTIATION; NERVE CONDUCTION; NEUROTOXICITY; NEURULATION; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

EID: 0742306813     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devbrainres.2003.10.004     Document Type: Article

References (52)

1. Aubert I., Cecyre D., Gauthier S., Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. J. Comp. Neurol. 369:1996;31-55.
2. Barone S., Das K.P., Lassiter T.L., White L.D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology. 21:2000;15-36.
3. Bomser J.A., Casida J.E. Diethylphosphorylation of rat cardiac M2 muscarinic receptor by chlorpyrifos oxon in vitro. Toxicol. Lett. 119:2001;21-26.
4. Bushnell P.J., Pope C.N., Padilla S. Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase. J. Pharmacol. Exp. Ther. 266:1993;1007-1017.
5. Chakraborti T.K., Farrar J.D., Pope C.N. Comparative neurochemical and neurobehavioral effects of repeated chlorpyrifos exposures in young and adult rats. Pharmacol. Biochem. Behav. 46:1993;219-224.
6. Cheney D.L., Lehmann J., Cosi C., Wood P.L. Determination of acetylcholine dynamics. Drugs Tools Neurotransm. Res. 12:1989;443-495.
7. Crumpton T.L., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos in vivo and in vitro: effects on nuclear transcription factor involved in cell replication and differentiation. Brain Res. 857:2000;87-98.
8. Dam K., Garcia S.J., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 116:1999;9-20.
9. Dam K., Seidler F.J., Slotkin T.A. Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity. Dev. Brain Res. 121:2000;179-187.
10. Dam K., Seidler F.J., Slotkin T.A. Transcriptional biomarkers distinguish between vulnerable periods for developmental neurotoxicity of chlorpyrifos: implications for toxicogenomics. Brain Res. Bull. 59:2003;261-265.
11. Garcia S.J., Seidler F.J., Crumpton T.L., Slotkin T.A. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res. 891:2001;54-68.
12. Garcia S.J., Seidler F.J., Qiao D., Slotkin T.A. Chlorpyrifos targets developing glia: effects on glial fibrillary acidic protein. Dev. Brain Res. 133:2002;151-161.
13. Garcia S.J., Seidler F.J., Slotkin T.A. Developmental neurotoxicity elicited by prenatal or postnatal chlorpyrifos exposure: effects on neurospecific proteins indicate changing vulnerabilities. Environ. Health Perspect. 111:2003;297-303.
14. Happe H.K., Murrin L.C. High-affinity choline transport regulation by drug administration during postnatal development. J. Neurochem. 58:1992;2053-2059.
15. Huff R.A., Corcoran J.J., Anderson J.K., Abou-Donia M.B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharmacol. Exp. Ther. 269:1994;329-335.
16. Icenogle L.M., Christopher C., Blackwelder W.P., Caldwell D.P., Qiao D., Seidler F.J., Slotkin T.A., Levin E.D. Behavioral alterations in adolescent and adult rats caused by a brief subtoxic exposure to chlorpyrifos during neurulation. Neurotoxicol. Teratol. 2004;. (in press).
17. Jope R.S. High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brains Res. Rev. 1:1979;314-344.
18. Klemm N., Kuhar M.J. Post-mortem changes in high affinity choline uptake. J. Neurochem. 32:1979;1487-1494.
19. Labarca C., Piagen K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:1980;344-352.
20. Lassiter T.L., Padilla S., Mortensen S.R., Chanda S.M., Moser V.C., Barone S. Gestational exposure to chlorpyrifos: apparent protection of the fetus? Toxicol. Appl. Pharmacol. 152:1998;56-65.
21. Lassiter T., White L., Padilla S., Barone S. Gestational exposure to chlorpyrifos: qualitative and quantitative neuropathological changes in the fetal neocortex. Toxicologist. 66:2002;632.
22. Lau C., Seidler F.J., Cameron A.M., Navarro H.A., Bell J.M., Bartolome J., Slotkin T.A. Nutritional influences on adrenal chromaffin cell development: comparison with central neurons. Pediatr. Res. 24:1988;583-587.
23. Levin E.D., Addy N., Christopher N.C., Seidler F.J., Slotkin T.A. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats. Dev. Brain Res. 130:2001;83-89.
24. Levin E.D., Addy N., Baruah A., Elias A., Christopher N.C., Seidler F.J., Slotkin T.A. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol. Teratol. 24:2002;733-741.
25. Levin E.D., Chrysanthis E., Yacisin K., Linney E. Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol. Teratol. 25:2003;51-57.
26. 3H]hemicholinium-3 binding in rat brain. Fundam. Appl. Toxicol. 34:1996;84-90.
27. Liu J., Pope C.N. Comparative presynaptic neurochemical changes in rat striatum following exposure to chlorpyrifos or parathion. J. Toxicol. Environ. Health. 53:1998;531-544.
28. Monnet-Tschudi F., Zurich M.G., Schilter B., Costa L.G., Honegger P. Maturation-dependent effects of chlorpyrifos and parathion and their oxygen analogs on acetylcholinesterase and neuronal and glial markers in aggregating brain cell cultures. Toxicol. Appl. Pharmacol. 165:2000;175-183.
29. Moser V.C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 149:1998;107-119.
30. Murrin L.C. High-affinity transport of choline in neuronal tissue. Pharmacology. 21:1980;132-140.
31. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., Slotkin T.A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251:1989;894-900.
32. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J. Toxicol. Environ. Health. 2:1999;161-181.
33. Qiao D., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ. Health Perspect. 109:2001;909-913.
34. Qiao D., Seidler F.J., Padilla S., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period? Environ. Health Perspect. 110:2002;1097-1103.
35. Qiao D., Seidler F.J., Tate C.A., Cousins M.M., Slotkin T.A. Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. Environ. Health Perspect. 111:2003;536-544.
36. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108(suppl. 3):2000;S511-S533.
37. Richardson J., Chambers J. Effects of gestational exposure to chlorpyrifos on postnatal central and peripheral cholinergic neurochemistry. J. Toxicol. Environ. Health. 66:2003;275-289.
38. Roy T.S., Andrews J.E., Seidler F.J., Slotkin T.A. Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology. 58:1998;62-68.
39. Sandstrom N.J., Loy R., Williams C.L. Prenatal choline supplementation increases NGF levels in the hippocampus and frontal cortex of young and adult rats. Brain Res. 947:2002;9-16.
40. Shelton D.L., Nadler J.V., Cotman C.W. Development of high affinity choline uptake and associated acetylcholine synthesis in the rat fascia dentata. Brain Res. 163:1979;263-275.
41. Simon J.R., Atweh S., Kuhar M.J. Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J. Neurochem. 26:1976;909-922.
42. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 107(Suppl. 1):1999;71-80.
43. Slotkin T.A., Seidler F.J., Crain B.J., Bell J.M., Bissette G., Nemeroff C.B. Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. Proc. Natl. Acad. Sci. U. S. A. 87:1990;2452-2455.
44. Slotkin T.A., Cousins M.M., Tate C.A., Seidler F.J. Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure. Brain Res. 902:2001;229-243.
45. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
46. Snedecor G.W., Cochran W.G. Statistical Methods. 1967;Iowa State University Press, Ames, Iowa.
47. Trauth J.A., Seidler F.J., Slotkin T.A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res. 867:2000;29-39.
48. 3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites. Life Sci. 35:1984;2335-2343.
49. Ward T.R., Mundy W.R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res. Bull. 39:1996;49-55.
50. Whitney K.D., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol. Appl. Pharmacol. 134:1995;53-62.
51. 3H]hemicholinium-3 binding. Neurotoxicol. Teratol. 14:1992;375-382.
52. Zahalka E., Seidler F.J., Lappi S.E., Yanai J., Slotkin T.A. Differential development of cholinergic nerve terminal markers in rat brain regions: implications for nerve terminal density, impulse activity and specific gene expression. Brain Res. 601:1993;221-229.